Fig 1.
CONSORT flow diagram.
Table 1.
Baseline characteristics of PETER PAIN study participants: People with HIV, chronic pain, and heavy alcohol use (n = 45).
Fig 2.
Mean change in pain severity and interference from baseline to 8 weeks.
Fig 3.
Mean pain severity overtime (baseline to 12 weeks).
Fig 4.
Mean pain interference overtime (baseline to 12 weeks).
Table 2.
Main results: Changes in primary and secondary outcomes from baseline to 8 weeks in the PETER PAIN trial.
Fig 5.
Mean cold pressor threshold overtime (baseline to 12 weeks).
Fig 6.
Mean in cold pressor tolerance overtime (baseline to 12 weeks).
Table 3.
Medication tolerability, discontinuations, adherence over the 8-week study period.
Table 4.
Medication satisfaction over 8-week study medication period.
Table 5.
Adverse events in gabapentin arm.
Table 6.
Adverse events in low-dose naltrexone arm.
Table 7.
Adverse events in placebo arm.